lutetium has been researched along with Carcinoma, Pancreatic Ductal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartholomeusz, D; Bezak, E; Hsieh, W; Hull, A; Li, Y; Pukala, TL; Staudacher, AH; Tieu, W | 1 |
| Baum, RP; Klette, I; Kulkarni, HR; Osterkamp, F; Reineke, U; Schuchardt, C; Singh, A; Smerling, C; Wiessalla, S | 1 |
2 other study(ies) available for lutetium and Carcinoma, Pancreatic Ductal
| Article | Year |
|---|---|
Preliminary Development and Testing of C595 Radioimmunoconjugates for Targeting MUC1 Cancer Epitopes in Pancreatic Ductal Adenocarcinoma.
Topics: Antibodies, Monoclonal; Carcinoma, Pancreatic Ductal; Copper Radioisotopes; Epitopes; Gallium Radioisotopes; Humans; Immunoconjugates; Lutetium; Mucin-1; Pancreatic Neoplasms; Radioisotopes; Technetium | 2022 |
Topics: Adenocarcinoma; Aged; Carcinoma, Pancreatic Ductal; Combined Modality Therapy; Drug Design; Female; Humans; Injections, Intravenous; Kidney; Lutetium; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Quality of Life; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Neurotensin; Retrospective Studies; Salvage Therapy; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome | 2018 |